<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma Limited has submitted its annual disclosure to BSE as required under SEBI's circulars dated November 26, 2018 and October 19, 2023, which govern fund raising through debt securities by large entities. In the filing, the company has declared that it is 'Not a Large Corporate' as per the framework laid out in those circulars. The disclosure is signed by Prakash Shah, Director (DIN: 01136800), and was dated April 23, 2025. This is a routine annual compliance submission and no financial figures or operational details are included.
This is a routine regulatory disclosure and is unlikely to have any material impact on the stock price. It simply confirms that the company falls below the threshold to be classified as a Large Corporate, meaning it is not required to mandatorily raise funds through debt securities under the SEBI framework.